Equities

Mediwound Ltd

Mediwound Ltd

Actions
  • Price (EUR)10.00
  • Today's Change0.00 / 0.00%
  • Shares traded4.71k
  • 1 Year change--
  • Beta--
Data delayed at least 15 minutes, as of Dec 22 2022.
More ▼
Find More Stocks
Find More Stocks
Use our equities screener to discover other potential opportunities.
 
Equities ScreenerGo to the Equities Screener

Financials data is unavailable for this security.

Balance sheet Back to Overview

In millions of USD
(except for per share items)
Fiscal data as of Dec 31 2023202320222021
ASSETS
Cash And Short Term Investments423411
Total Receivables, Net4.429.532.27
Total Inventory2.851.961.20
Prepaid expenses0.720.460.44
Other current assets, total----0
Total current assets504615
Property, plant & equipment, net163.584.03
Goodwill, net------
Intangibles, net0.170.230.30
Long term investments------
Note receivable - long term0.050.180.28
Other long term assets------
Total assets665020
LIABILITIES
Accounts payable------
Accrued expenses2.112.471.64
Notes payable/short-term debt000
Current portion long-term debt/capital leases0.360.530.60
Other current liabilities, total2.833.403.79
Total current liabilities111211
Total long term debt6.350.851.39
Total debt6.711.381.99
Deferred income tax------
Minority interest------
Other liabilities, total182612
Total liabilities353924
SHAREHOLDERS EQUITY
Common stock0.180.140.08
Additional paid-in capital206179144
Retained earnings (accumulated deficit)(175)(168)(149)
Treasury stock - common------
Unrealized gain (loss)------
Other equity, total(0.02)(0.01)(0.02)
Total equity3211(4.58)
Total liabilities & shareholders' equity665020
Total common shares outstanding9.227.243.90
Treasury shares - common primary issue000
Data Provided by LSEG
All markets data located on FT.com is subject to the FT Terms & Conditions
All content on FT.com is for your general information and use only and is not intended to address your particular requirements. In particular, the content does not constitute any form of advice, recommendation, representation, endorsement or arrangement by FT and is not intended to be relied upon by users in making (or refraining from making) any specific investment or other decisions.
Any information that you receive via FT.com is at best delayed intraday data and not "real time". Share price information may be rounded up/down and therefore not entirely accurate. FT is not responsible for any use of content by you outside its scope as stated in the FT Terms & Conditions.